Flatiron Blog Informing global evidence strategies with real-world data across multiple geographies Published on January 29, 2026 By Arun Sujenthiran, MD SharePosted inReal-World EvidenceRegulatoryHTA and Market AccessLife sciencesReal-World Data More to exploreWebinar: An HEOR playbook for oncology RWE and AI use to support European HTAReal-World EvidenceWebinarLife sciencesHEOR / RWEReal-World DataWhat we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA expertsReal-World EvidenceLife sciencesHEOR / RWEReal-World DataMultinational dataOne Standard, Many Markets: What FDA, EMA, and PMDA Actually Agree OnReal-World EvidenceRegulatoryLife sciencesReal-World Data
Webinar: An HEOR playbook for oncology RWE and AI use to support European HTAReal-World EvidenceWebinarLife sciencesHEOR / RWEReal-World Data
What we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA expertsReal-World EvidenceLife sciencesHEOR / RWEReal-World DataMultinational data
One Standard, Many Markets: What FDA, EMA, and PMDA Actually Agree OnReal-World EvidenceRegulatoryLife sciencesReal-World Data
